Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis

Early endpoints, such as progression-free survival (PFS), are increasingly used as surrogates for overall survival (OS) to accelerate approval of novel oncology agents. Compiling trial-level data from randomized controlled trials (RCTs) could help to develop a predictive framework to ascertain corre...

Descripción completa

Detalles Bibliográficos
Autores principales: Shameer, Khader, Zhang, Youyi, Jackson, Dan, Rhodes, Kirsty, Neelufer, Imran Khan A., Nampally, Sreenath, Prokop, Andrzej, Hutchison, Emmette, Ye, Jiabu, Malkov, Vladislav A., Liu, Feng, Sabin, Antony, Weatherall, Jim, Duran, Cristina, Iacona, Renee Bailey, Khan, Faisal M., Mukhopadhyay, Pralay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351517/
https://www.ncbi.nlm.nih.gov/pubmed/34381708
http://dx.doi.org/10.3389/fonc.2021.672916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351517/
https://www.ncbi.nlm.nih.gov/pubmed/34381708
http://dx.doi.org/10.3389/fonc.2021.672916

Ejemplares similares